Crossmark

Multicenter, PrOspective, Randomized, Controlled Trial Comparing GenIcular Artery EmbOlization Using Embosphere Microspheres to Corticosteroid iNjections for the Treatment of Symptomatic Knee Osteoarthritis: MOTION Study Protocol Summary

Crossref DOI link: https://doi.org/10.1007/s00270-025-03994-z

Published Online: 2025-03-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bent, Clare https://orcid.org/0000-0001-5190-2694
McAsey, Craig J.

Bagla, Sandeep
Funding

Funding for this research was provided by:

Merit Medical Systems
License Information

Text and Data Mining valid from 2025-03-06

Version of Record valid from 2025-03-06
More Information

Article History

Received: 26 September 2024

Accepted: 17 February 2025

First Online: 6 March 2025

Declarations

:

: CB: Lecturer for Merit Medical Systems, Inc. SB: Consultancy and clinical research for Merit Medical Systems, Inc.; educational grant from Asahi Medical; consultant and clinical research for Terumo; consultant and clinical research for Crannmed; clinical research for Guerbet. CJM: Nothing to disclose.

: Ethics approval has been granted by local ethics committees for each center participating in the study (Protocol no.: GAE-P3-22-01, version 2, February 16, 2024).

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent will be obtained from all patients included in the study.

: Not applicable.

Document is current

Any future updates will be listed below